No Data
No Data
While Xiangxue PharmaceuticalLtd (SZSE:300147) Shareholders Have Made 28% in 1 Year, Increasing Losses Might Now Be Front of Mind as Stock Sheds 9.2% This Week
Xiangxue Pharmaceuticals: Semi-Annual Report 2024
Xiangxue Pharmaceuticals: 2024 Semi-Annual Report Summary
Xiangxue Pharmaceutical (300147.SZ) released its performance for the first half of the year, with a net loss of 0.135 billion yuan, and the loss expanded.
Xiangxue Pharmaceutical (300147.SZ) released its 2024 interim report, with revenue of 1.097 billion yuan...
Xiangxue Pharmaceutical (300147.SZ): Net loss of 0.135 billion yuan in the first half of the year, with an expanded loss compared to the same period last year.
Xiangxue Pharmaceutical (300147.SZ) announced its semi-annual report for 2024, with operating revenue of 1.097 billion yuan, a 8.72% decrease compared to the same period last year; net income attributable to shareholders of the listed company was -0.135 billion yuan, with an increased loss compared to the same period last year; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was -0.108 billion yuan; basic earnings per share was -0.2 yuan.
Xiangxue Pharmaceutical Co.,Ltd.'s (SZSE:300147) Price Is Right But Growth Is Lacking After Shares Rocket 25%
No Data
No Data